125 related articles for article (PubMed ID: 17163759)
1. Mechanistic basis for therapeutic targeting of the mitochondrial F1F0-ATPase.
Johnson KM; Cleary J; Fierke CA; Opipari AW; Glick GD
ACS Chem Biol; 2006 Jun; 1(5):304-8. PubMed ID: 17163759
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulatory benzodiazepine Bz-423 inhibits B-cell proliferation by targeting c-myc protein for rapid and specific degradation.
Sundberg TB; Ney GM; Subramanian C; Opipari AW; Glick GD
Cancer Res; 2006 Feb; 66(3):1775-82. PubMed ID: 16452238
[TBL] [Abstract][Full Text] [Related]
3. NMR studies of an immunomodulatory benzodiazepine binding to its molecular target on the mitochondrial F(1)F(0)-ATPase.
Stelzer AC; Frazee RW; Van Huis C; Cleary J; Opipari AW; Glick GD; Al-Hashimi HM
Biopolymers; 2010 Jan; 93(1):85-92. PubMed ID: 19768783
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine-based selective inhibitors of mitochondrial F1F0 ATP hydrolase.
Hamann LG; Ding CZ; Miller AV; Madsen CS; Wang P; Stein PD; Pudzianowski AT; Green DW; Monshizadegan H; Atwal KS
Bioorg Med Chem Lett; 2004 Feb; 14(4):1031-4. PubMed ID: 15013017
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423.
Johnson KM; Chen X; Boitano A; Swenson L; Opipari AW; Glick GD
Chem Biol; 2005 Apr; 12(4):485-96. PubMed ID: 15850986
[TBL] [Abstract][Full Text] [Related]
6. N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolase.
Atwal KS; Ahmad S; Ding CZ; Stein PD; Lloyd J; Hamann LG; Green DW; Ferrara FN; Wang P; Rogers WL; Doweyko LM; Miller AV; Bisaha SN; Schmidt JB; Li L; Yost KJ; Lan HJ; Madsen CS
Bioorg Med Chem Lett; 2004 Feb; 14(4):1027-30. PubMed ID: 15013016
[TBL] [Abstract][Full Text] [Related]
7. Identification of compounds that bind mitochondrial F1F0 ATPase by screening a triazine library for correction of albinism.
Williams D; Jung DW; Khersonsky SM; Heidary N; Chang YT; Orlow SJ
Chem Biol; 2004 Sep; 11(9):1251-9. PubMed ID: 15380185
[TBL] [Abstract][Full Text] [Related]
8. Energetic signalling in the control of mitochondrial F1F0 ATP synthase activity in health and disease.
Grover GJ; Marone PA; Koetzner L; Seto-Young D
Int J Biochem Cell Biol; 2008; 40(12):2698-701. PubMed ID: 18707016
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia.
Grover GJ; Malm J
Cardiovasc Ther; 2008; 26(4):287-96. PubMed ID: 19035880
[TBL] [Abstract][Full Text] [Related]
10. Atypical subunit composition of the chlorophycean mitochondrial F1FO-ATP synthase and role of Asa7 protein in stability and oligomycin resistance of the enzyme.
Lapaille M; Escobar-Ramírez A; Degand H; Baurain D; Rodríguez-Salinas E; Coosemans N; Boutry M; Gonzalez-Halphen D; Remacle C; Cardol P
Mol Biol Evol; 2010 Jul; 27(7):1630-44. PubMed ID: 20156838
[TBL] [Abstract][Full Text] [Related]
11. Multi-site TBT binding skews the inhibition of oligomycin on the mitochondrial Mg-ATPase in Mytilus galloprovincialis.
Nesci S; Ventrella V; Trombetti F; Pirini M; Pagliarani A
Biochimie; 2011 Jul; 93(7):1157-64. PubMed ID: 21530606
[TBL] [Abstract][Full Text] [Related]
12. Identification of the F1F0 mitochondrial ATPase as a target for modulating skin pigmentation by screening a tagged triazine library in zebrafish.
Jung DW; Williams D; Khersonsky SM; Kang TW; Heidary N; Chang YT; Orlow SJ
Mol Biosyst; 2005 May; 1(1):85-92. PubMed ID: 16880968
[TBL] [Abstract][Full Text] [Related]
13. Effect of the ATPase inhibitor protein IF1 on H+ translocation in the mitochondrial ATP synthase complex.
Zanotti F; Gnoni A; Mangiullo R; Papa S
Biochem Biophys Res Commun; 2009 Jun; 384(1):43-8. PubMed ID: 19379707
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent inhibition of mitochondrial ATP synthase by 17 beta-estradiol.
Massart F; Paolini S; Piscitelli E; Brandi ML; Solaini G
Gynecol Endocrinol; 2002 Oct; 16(5):373-7. PubMed ID: 12587531
[TBL] [Abstract][Full Text] [Related]
15. Modifiers of the oligomycin sensitivity of the mitochondrial F1F0-ATPase.
Pagliarani A; Nesci S; Ventrella V
Mitochondrion; 2013 Jul; 13(4):312-9. PubMed ID: 23597783
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases.
Boyd MR; Farina C; Belfiore P; Gagliardi S; Kim JW; Hayakawa Y; Beutler JA; McKee TC; Bowman BJ; Bowman EJ
J Pharmacol Exp Ther; 2001 Apr; 297(1):114-20. PubMed ID: 11259534
[TBL] [Abstract][Full Text] [Related]
17. Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase.
Chi SL; Wahl ML; Mowery YM; Shan S; Mukhopadhyay S; Hilderbrand SC; Kenan DJ; Lipes BD; Johnson CE; Marusich MF; Capaldi RA; Dewhirst MW; Pizzo SV
Cancer Res; 2007 May; 67(10):4716-24. PubMed ID: 17510399
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of cruentaren A analogues.
Vintonyak VV; Calà M; Lay F; Kunze B; Sasse F; Maier ME
Chemistry; 2008; 14(12):3709-20. PubMed ID: 18306263
[TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanisms of proton-translocating F(O)F (1)-ATP synthase.
Feniouk BA; Yoshida M
Results Probl Cell Differ; 2008; 45():279-308. PubMed ID: 18026702
[TBL] [Abstract][Full Text] [Related]
20. A yeast mitochondrial ATPase inhibitor interacts with three proteins that are easy to dissociate from the mitochondrial inner membrane.
Ichikawa N; Nakabayashi K; Hashimoto T
J Biochem; 2002 Oct; 132(4):649-54. PubMed ID: 12359082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
